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Summary 
We demonstrate that cognate peptide llgands altered 
at T cell receptor (TCR) contact residues and bound to 
class II major histocompatablllty complex can change 
the cytokine pattern of mature T cell clones. Myelln 
basic protein peptlde 8888-reactive ThO T cell clones 
were stimulated wlth altered peptlde ligands, which 
acted both as TCR antagonist and Induced new mRNA 
synthesis and proteln secretion of TGF-81, while no 
longer inducing mRNA synthesis or protein secretlon 
of IL-2, IL-4, IL-lo, and IFNT. The modffied peptldes 
falled to induce a detectable caklum flux, ~88” actlva- 
tion, or thymldine Incorporatlon, yet triggered nearfy 
equal amounts of IL-4 secretlon in the presence of ion- 
omycin. Antigen-Induced modulation of T cell cytoklne 
secretion may be important In regulating the Immune 
response. 
lntroductlon 
Naive T cells differentiate into distinct populations defined 
by their cytokine secretion pattern and regulatory function. 
Thl cells secrete predominantly interleukin-2 (IL-2) and 
interferon y(lFNy) and are involved in classic delayed-type 
hypersensitivity reactions, while Th2 cells, which secrete 
predominantly IL4 and 11-10, induce selected immuno- 
globulin secretion and can down-regulate Thl-mediated 
immune responses (Mossmann et al., 1986; Romagnani, 
1994). Thus, cytokines secreted by T cells after activation 
qualitatively influence the nature of the immune response. 
Recent reports have suggested that the dominant factors 
determining the maturation of naive T cells into either pre- 
dominantly Thl or Th2 cells are cytokines, particularly IL- 
12 and IFNy for Thl and IL4 for Th2 (Seder and Paul, 
1994). Other factors include the dose and type of antigen, 
the type of antigen-presenting cell (APC), and costimula- 
tory molecules involved in activation. Once T cells have 
differentiated into Thl or Th2 type T cells, they are thought 
to be committed to the production of a given set of lympho- 
kines upon restimulation. 
T cell secretion of certain cytokines is also implicated in 
the induction and regulation of autoimmune inflammatory 
disease, which is mediated by activated autoreactive T 
cells that recognize tissue-specific antigen in the context 
of major histocompatibility complex (MHC) class II mola 
cules on APCs. In experimental autoimmune encephalo- 
myelitis (EAE), a model for multiple sclerosis, evidence 
suggests that T cell secretion of 11-2, IFNT, and tumor 
necrosis factor (TNF) may mediate inflammation and tis- 
sue damage, while the secretion of IL4, IL-lo, and trans- 
forming growth factor-61 (TGF-61) by myelin basic protein 
(MBP)-reactive T cells is associated with potent suppres- 
sor activity and down-regulation of central nervous system 
inflammation (Miller et al., 1992). The induction of TGF-81 
secretion appears to be of particular importance in regulat- 
ing EAE, as anti-TGF-61 monoclonal antibodies inhibit the 
suppressor effect of regulatory MBP-reactive T cells (Chen 
et al., 1994). Thus, autoreactive T cells are not necessarily 
pathologic and can function to down-regulate immune re- 
sponses associated with tissue inflammation locally. 
It has recently become clear that T cell activation is not 
a simple on/off response. Allen and coworkers (Evavold 
and Allen, 1991; Evavold et al., 1993a) demonstrated that 
stimulation of a T cell clone wtth modified peptide-anti- 
gens that trigger a suboptimal TCR signal can induce cy- 
tokine secretion or IL-2 receptor expression and cytolysis 
without thymidine incorporation. Altered peptides have 
also been shown to act as TCR antagonists or to induce 
anergy in Thl and Th2 clones (Alexander et al., 1993; De 
Magistris et al., 1992; Jameson et al., 1993; Ostrov et al., 
1993; Ruppert et al., 1993; Sloan-Lancaster et al., 1993, 
1994). The ability of altered peptide ligands to induce dif- 
ferent signaling events prompted us to examine their ef- 
fects on cytokine secretion using human autoreactive T 
cell clones recognizing the immunodominant myelin basic 
protein epitope 85-99 (MBPp85-99). 
Results 
Blndlng of Altered Peptlde Llgando to DRBl l 1501 
and Peptlde Fine Specificity of T Cell 
Clone Obl Al 2 
Altered peptide ligands derived from MBPp85-99 were 
examined for binding to DRBl’1501 in an MHC competi- 
tion assay and for the ability to stimulate MBPp85-99 
reactive T cell clone OblAl2 (Table 1). This clone did not 
proliferate or incorporate thymidine after stimulation with 
MBPp85-99 substituted at amino acid positions 90 and 
91, while an alanine substitution at position 93 did not 
significantly alter the T cell response, indicating that posi- 
tions 90 and 91 are the critical TCR contact points for 
this clone. Whereas substitutions at positions 69 and 92 
significantly reduced binding of the altered peptides to 
DRBl “1501, substitutions at positions 90,91, and 93 did 
not reduce binding, confirming positions 89 and 92 in 
MBPp85-99 are the major MHC contact points. 
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Table 1. Altered Peptide Ligand Stimulation of MBP Reactive T Cell Clone OblA12 and Binding to Class II MHC 
MBPpE5-QQ Sequence Binding to DRB’ISOI 
[SH]Thymidine IC50% Ratlo binding 
05 86 07 00 09 90 91 92 93 94 95 96 97 98 QQ uptake nM to p&5-99 
ENPVVHFFKNIVTPR+tt 4.1 1 
K + 404 0.01 
A - 5.2 0.8 
D 76 0.055 
K 7 0.59 
A 2.1 2.0 
A f 283 0.025 
A ++ 3.5 1.2 
APCs were pulsed with peptide at l-100 us/ml for 2 hr, washed, and irradiated with 5000 rads. T cells (5 x 10’) and APCs (2 x 10’) were then 
cocultured in triplicate for 3 days in 200 ul medium at 37OC. T cell proliferation was measured as [‘H]thymidine incorporation after an 18 hr pulse. 
Trfple pluses represent proliferation (stimulation index >3) at 1 uglml; double pluses represents prollferatlon at IO uglml; and a single plus represents 
proliferation only at 100 ug/ml of peptide. 
TCR Antagonist Properties of Altered 
Peptide Ligands 
The biologic activity of peptides with substitutions at posi- 
tion 90 were examined in a prepulse TCR-antagonist ex- 
periment in which T cells are stimulated by APCs that 
were pulsed with a limited concentration of native peptide, 
followed 2 hr later by stimulation with increasing concen- 
trations of peptide antagonist. This assay was developed 
to avoid competition between antigen and antagonist at 
the MHC level and thus allows measurement of events at 
the TCR level (De Magistris et al., 1992). TCR antagonism 
has been attributed to active signaling events resulting in 
the inhibition of early biochemical events required for T 
ceil activation rather than just competition for TCR binding 
with the native peptide (Ruppert et al., 1993). As shown 
in Figure 1, MBPp65-99 peptides altered at position 90 
could inhibit proliferation induced by the native peptide, 
suggesting that they could act as a TCR ligand and signal 
in the context of class II MHC. These altered peptide li- 
gands did not induce clonal unresponsiveness as the T 
cells showed a full proliferative response to MBPp65-99 
7 days after the initial peptide stimulation (data not shown). 
MBPp65-99 with an alanine substitution at position 91 
(MBPp65-99[91A]) inhibited proliferation of OblA12 to a 
much lesser degree, even at concentrations of 100 ugl 
ml, suggesting that this peptide-MHC complex had a low 
TCR affinity as compared with the peptides with substitu- 
tions at position 90 (Figure 1). As expected, peptide 
MBPp65-99(93A) acted as an agonist similar to the native 
peptide. 
Signaling PropertIes of Altered Peptide Llgands 
Antigen-specific activation of T cells results in a cascade 
of events involving Ca2+ influx and activation of the CD4- 
associated protein tyrosine kinase ~56~ leading to a mo- 
bility shift of ~56~ to p6olck on gel electrophoresis (Ber- 
ridge, 1993; Rudd et al., 1994). To examine further the 
signaling properties of the modified peptides and to pro- 
vide definitive evidence of TCR ligation, we investigated 
the biochemical consequences of ligating the TCR with 
MBPp65-99 and the substituted peptides. CDeassoci- 
ated ~56~ was immunoprecipitated and tested in an in 
vitro autophosphoryiation assay. Whereas MBPp65-99 
and p(93A), both of which induced thymidine incorporation 
in OblAl2, were able to induce a mobility shift in psSM 
to p6tY, p(9OA) and p(91A) did not (Figure 2A). Likewise, 
MBPp65-99 induced a strong Ca2+ influx in contrast with 
p(9OA) (Figure 28). T cells can bs activated by a combina- 
tion of ionomycin and phorbol myrtstate acetate (PMA), 
which induce a Ca2+ flux and direct protein kinase C acttva- 
tion (resulting in ~56~ activation), respectively. As p(9OA) 
signaled the T cell without a measurable Caa flux, it was 
of interest to examine 13H]thymidine incorporation and cy- 
tokine secretion in the presence of either ionomycin or 
PMA with antigen. Stimulation of OblA12 with p(9OA) in 
the presence of ionomycin induced significant amounts 
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Figure I. MBP 85-99 Peptides Substituted at Position QO Act as TCR 
Antagonists 
APCs prepulsed for 2 hr with limiting concentrations of native pepttde 
(2ugIml)followed byasecondpulseofantigenwtth theafteredpeptlde 
ligands at 0.1, 1, 10, and 100 pg/ml for 2 hr were added to the T cell 
clone CblAl2 (5 x l(r APCs and 2 x 10 T cells) and cocultured 
for 3 days as described in Experimental Procedures A representattve 
of three experiments is shown. Standard error bars indicate the varla- 
tion within the triplicate wellsof each condition. The native MBPp85-QQ 
and MBPpM%QQ(Q3A), which were agonist peptides (open symbols), 
were used as positive controls. Closed symbols denote peptides that 
did not induce primary proliferation. Note that MBPp85-QQ(QlA) is 
effects. 
;;~ed Peptide Ligand Modulated Cytokine Secretion 
p60 Ick+ 
~56 ‘=k-) 
Figure 2. Signaling Events Associated with Al- 
tered Peptide Ligand Stimulation 
(A) MBPp9599 and p(9SA) but not p(9OA) and 
p(91A) trigger phosphorylattn of pFW in 
OblA12.OblA12 wasstimulated with peptide 
pulsed APCs for 1 hr; CD4 immunopracipltated 
followed by in vitro kinase assay as described 
in Experimental Procedures. 
(B) MEPp99-99 but not p(9OA) induces a Ca2+ 
flux in CblA12. Addition of ionomycin (4 ug/ 
ml) was used as a positive control and EGTA 
(5 &ml) as negative control. 
(C)Addition of ionomycin but not PMA top(9OA) 
and p(9OK) reconstitutes IL4 secretion of 
OblA12. T cells(2 x 109 and APCs (109 were 
cocultured in triplicate wells in medium supple- 
mented with ionomycin at 109 nglml or PMA 
at 10 rig/ml. A representative of three experi- 
ments is shown. 
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of IL4 (Figure 2C) but not IL-10 or IFNy secretion or 
PH]thymidine incorporation. These findings suggest that 
the p@OA)/DRBl l 1501 complex provided a partial TCR 
signal. 
T Cell Stimulation with Altered Peptlde Llgands 
Speclfically Induces TGF-fll mRNA 
Direct measurement of cytokine mRNA levels following 
stimulation with altered peptide ligands substituted at the 
TCR contact residues were examined by reverse tran- 
scriptase-polymerase chain reaction (RT-PCR). Stimula- 
tion of OblA12 with MBPp65-990r p(93A) induces mRNA 
expression of 11-2, IL4, IL-lo, and IFNy but not TGF-31 
as shown for IL4 and TGF-61 in Figure 3. The altered 
peptide ligands that failed to induce thymidine incorpora- 
tion also failed to induce IL-2,114, IL-lo, and IFNy mRNA 
synthesis at different timepoints after T cell stimulation 
(data not shown). However, TGF-91 mRNA was induced 
after stimulation of OblA12 with MBPp66-99(9OA) (Figure 
3A). A second human MBPp66-99reactive T cell clone, 
Ob3D1, from the same patient with a different peptide 
fine specificity was examined. This clone also has a ThO 
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Figure 3. Modulation of TGF)3-1 and IL-4 mRNA with Altered Peptide 
Ligand Stimulation 
Expression of TGF-f.tl and IL-4 mRNA in human MSP 85-W-reactive 
T cell clones OblA12 (A) and ObSDl (6) following stimulation with 
MSPpEb-99, p(goA) and p(g3A). Total RNA was extracted after 4 hr, 
reverse transcribed into cDNA, and assayed by semiquantltative PCR 
for expression of cytokine mRNA. These findings were reproduced in 
four independent experiments for OblA12 and twice for Ob3Dl. 
cytokine profile and proliferates to MBPp88-99 and (gOA), 
while substitutions at position 93 result in loss of reactivity, 
indicating that the lysine at this position is a critical TCR 
contact residue. Stimulation with MBPp85-99(93A) but 
not MBPp85-99 or (SOA) induced significant mRNA ex- 
pression of TGF-81 (Figure 38). 
Switch in Cytokine Secretion after T Cell Stimulation 
with Altered Peptide Ugands 
The secretion of cytokines into the culture supernatant 
after stimulation of T cell clone OblA12 with altered pep- 
tides was measured by enzyme-linked immunosorbent 
assay (ELISA) (Figure 4). In accordance with the findings 
of mRNA expression, 11-2, IL+, 11-10, and IFNy were se- 
creted after stimulation with the wild-type peptide. Secre- 
tion of these cytokines correlated with T cell proliferation 
and was abolished when peptides with substitutions at 
TCR contact points were used for stimulation. Reduced 
cytokine secretion after stimulation with MBPp88-99(89K) 
and p(92A) corresponds to the reduced MHC binding of 
these peptides as shown in Table 1. Only MBPp88-99(99A) 
and (9OD) induced TGF-81 secretion, corresponding to the 
induction of mRNA synthesis. Hence, these MBP analog 
peptides switched cytokine secretion patterns by selec- 
tively inducing mRNA synthesis and protein secretion of 
TGF-81 in the absence of thymidine incorporation or se- 
cretion of IL-2,114 IL-lo, or IFNy. TGF-81 secretion could 
not be detected by ELISA in clone Ob3Dl in spite of spe- 
cific induction of TGF-81 mRNA synthesis, which might 
be due to either posttranscriptional regulation or autocrine 
usage of the secreted TGF-81 by this T cell clone. 
It was possible that the induction of TGF-81 secretion 
by the altered peptide ligand was due to an attenuated T 
cell activation. The consequences of lowering the native 
peptide concentration for the induction of TGF-81 synthe- 
sis was examined. OblA12 was stimulated with either the 
native MBPp88-99 peptide or (99A) peptide at lower con- 
centrations and the secretion of IL-t, IFNy, and TGF-81 
measured. With lowered peptide concentrations, T cell 
activation was decreased as measured by IL4 or IFNr 
secretion (Figure 5) or PH]thymidine incorporation (data 
not shown) without the induction of TGF-81 secretion. This 
suggests that the induction of TGF-81 secretion by altered 
peptide ligands was not due to attenuated Tcell activation. 
In addition, costimulation with ionomycin and PMA with 
the altered ligands did not induce TGF8 secretion. 
The production of active TGF-81 is not exclusively tran- 
scriptionally regulated, since a latent form of the cytokine 
is secreted from the cell and postsecretional activation 
must occur (Wahl, 1991). Thus, in these experiments, we 
measured the production of the active TGF-81 by ELISA. 
Since TGF-81 can be released from dying cells, cell viabil- 
ity after 3 days in culture was examined by trypan blue 
uptake and was found to be similar in all conditions, indi- 
cating that the altered peptide ligands did not induce cell 
death. Although we cannot exclude the possibility that 
peptide analogs are inducing T cells to signal the APCs 
that then secondarily secrete TGF-81 this seems unlikely, 
since comparable results were obtained using DRBl l 1891- 
transfected L cells as APCs (data not shown). 
Discussion 
In this report, we show that the stimulation of human auto- 
reactive T cell clones by altered peptide ligand-MHC com- 
plexes induces a switch in the cytokine pattern from a ThO 
to a TGF-81 secreting phenotype. This demonstrates that 
the antigen itself plays an important role in the regulation 
of T cell function even after T cell differentiation. 
Recent studies have shown that the stimulation of T 
cells with peptide ligands substituted at so-called primary 
TCR contact residues fails to elicit any measurable re- 
sponse, while peptides substituted at so-called secondary 
TCR contact residues can function as partial agonists 
(Evavold et al., 1993b). Phe-91 appears to represent the 
primary TCR contact residue for the clones OblA12 and 
Ob3D1, since peptides with substitutions at this position 
do not induce any response. Indeed, none of the pre- 
viously tested DRBl’1501-restricted MBPp88-99-reac- 
tive T cell clones tolerate a substitution at this position 
(Wucherpfennig et al., 1994). Histidine at position 90 for 
clone OblA12 and lysine at position 93 for clone Ob3Dl 
appear to serve as secondary TCR contact residues. 
These results are consistent with the paradigm of partial 
agonist peptides having alterationsof secondary TCR con- 
tact residues, whereas no response or only weak TCR 
antagonism was observed with peptides modified at the 
primary TCR contact point. 
Altered peptide ligand signaling through the TCR may 
be due to differential allosteric changes in the TCRaf3 
chains resulting in selective triggering of secondary mes- 
sengers (Rojo et al., 1989). The molecular mechanism 
involved in the switch of cytokine secretion after stimula- 
tion of the T cell clones with altered peptide ligands re- 
$I& Peptide Ligand Modulated Cytokine Secretion 
IL-4 IL-1 0 y-IFN Figure 4. Cyiokine Secretion of TGF+l, 11-2, 
‘-F-l 
11-4, 11-10, and IFNy of T Cell Clone OblA12 
Following Stimulation with MBPpB54 and Al- 
tered Peptide Ligands 
c L, , !b 1 Tcells(lO”)fromOblA12werestimulatedwith 
0 .02 .M .06 0 025 0.5 075 0 2.5 5.0 7.5 0 0.5 1.0 1.5 0 0.5 1.0 1.5 2.0 4 x 1Q pepMe-pulsed APCs. Supematants for the ELlBAs were taken after 40 hr for 11-2, 
pg/ml secreted cytokine x 10-J IL-l, IL-lo, and IFNy and for TGF+l after 72 
hr from the stalt of experiment. Assays were 
performed in duplicate; experiments shown are 
representative of four independent experi- 
ments (standard error bars). 
mains unclear. Weshowed here that MHC-altered peptide 
complexes do not activate early intracellular signaling 
events of antigen-dependent T cell activation such as Ca% 
influx or ~56~ activation. However, these altered peptides 
efficiently inhibit antigen-dependent T cell proliferation 
and can induce IL-4 but not TGFP secretion in the pres- 
ence of ionomycin. Additionally, induction of TGF$l se- 
cretion by the altered peptide ligand was not simply due 
to an attenuated T cell activation. Thus, our findings are 
compatible with a model in which the altered peptide en- 
gages the TCR with the same affinity as native peptide 
but instead triggers a different set of signals leading to 
alterations in the final cytokine secretion pattern. 
A change in cytokine secretion pattern from a ThO type 
clone to a TGFf3-1 or IL-4 secreting clone may have im- 
portant physiologic consequences. TGF-Pl has a broad 
spectrum of cellular targets and affects many functions in 
nearly all cells. It is a potent regulator of the immune sys- 
tem, generally functioning as an immunosuppressant, 
inhibiting the proliferation of T and B lymphocytes at fem- 
tomolar concentrations (Kehrl et al., 1966a, 1966b). A 
prominent role for TGF-pl in the normal homeostasis of 
the immune system is suggested by the excessive inflam- 
matory response and multifocal inflammatory cell infiltra- 
tion seen in transgenic TGF-Pl knockout mice (Kulkarni 
et al., 1993; Shull et al., 1992). Moreover, in the animal 
model EAE, TGF-Bl administration to mice has been 
shown to protect and ameliorate disease (Racke et al., 
1991). Oral administration of low doses of MBP resulting 
in suppression of EAE is associated with the generation 
of T cells, which secrete TGF-fil after antigen-specific 
stimulation (Miller et al., 1992, 1993). Similarly, IL-4 and 
TGF-bl have both been associated with recovery from 
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EAE (Khoury et al., 1992), and selective secretion of IL-4 
by altered peptide ligands is therefore likely to be important 
in the regulation of immune responses to self-antigen. 
Natural modifications of MBP amino acids such as the 
arginine derivative, citrulline, or phosphorylation of argi- 
nine and hi&dine, which occur as posttranslational modifi- 
cations or during the breakdown and metabolism of MBP 
(Smith et al., 1976; Wold, 1961), might be expected to 
regulate and limit autoimmune responses to self-proteins 
by the mechanism shown here. Recent studies implicate 
a role of altered peptide ligands in T cell selection in the 
thymus (Ashton-Rickardt et al., 1994; Hogquist et al., 
1994) and naturally occurring variants of virus epitopes 
that act as T cell antagonists in vivo can be isolated from 
humans (Bertoletti et al., 1994; Klenerman et al., 1994). 
The obsewations reported here have obvious therapeu- 
tic implications for antigen-specific modifications of im- 
mune responses. Adoptive transfer of MBP-reactive T cell 
clones from orally tolerized mice using the same TCR as 
encephalitogenic T cell clones but secreting TGF+31 has 
been shown to inhibit experimental autoimmune encepha- 
lomyelitis (Chen et al., 1994). Altered peptide ligands can 
effectively modify the course of EAE, as recently shown 
using peptides derived from proteolipid protein peptide 
139-151 and substituted at the primary TCR contact 
points (Kuchroo et al., 1994). These modified peptides 
protect mice from EAE and induce protective T cells that 
cross-react with the native peptide (L. 8. Nicholson and 
V. K. Kuchroo, personal communication). Thus, theadmin- 
istration of MBP analog peptides may similarly allow the 
in vivo generation of TGF-pl -secreting autoreactive Tcells 
capable of migrating to the central nervous system and 
suppressing local inflammatory responses. 
PEPTIDE CONCENTRATION bg/mll 
Figure 5. Cytokine Secretionof 11-4, IFNy, and 
TGF-Bl of T Cell Clone OblA12 Following 
Stimulation with MBPpS5-gg and Altered Pep 
tide Ligand MBPp&%gg@OA) at Merent Con- 
centrations 
T cells (lg from Obl Al2 were stimulated with 
diirent concentrations of peptide-pulsed 
APCs. Supematants for the ELlSAs weretaken 
after 40 hr for IL-4 and IFNy and after 72 hr 
from the start of the experiment for TGF-Bl. 
Assays were performed in duplicate, and ex- 
periments shown are representative of two in- 
- .- -- 
less than 10% and are not shown). 
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Experlmentel Procedures 
T Cell Clones 
T cell clones OblA12 and Ob3Dl were generated from peripheral 
blood mononuclear cells of a multiple sclerosis patient by limiting dilu- 
tion cloning as described previously (Cta et al., 1990). The clones 
were maintained in fetal calf serum, 10% DMSC in liquid nitrogen. 
Aliquots of frozen T cell clones were thawed, washed in RPM1 1640, 
213% fetal calf serum, and restimulated with 1 pg/ml PHA.P and alloge- 
nit PBMCs as feeder cells in complete medium (RPM1 1640 supple- 
mented with 10% pooled human A/B serum, 2 mM Lglutamine, 10 
mM HEPES, and 100 U/l 00 pg psr ml psnicillin/streptomycin). After 
3 days, IL-2 (human T cellStim, Becton-Dickinson, Mountain View, 
California) was added to a final concentration of 5%. The medium was 
changed every 3 to 4 days. Cells were expanded for 8-10 days: 16 
hr before the experiments, cells were put into IL-2-free medium. 
Bfndlng of MBP PePttdes to MHC 
MBPp85-99 (ENPWHFFKNIVTPR) and altered peptides were syn- 
thesized in the Biopolymer Laboratory, Harvard Medical School, by 
automated solid-phase methods using FMCC-protected amino acid 
precursors and pu rifted by revere phase high pressure liquid chroma- 
tography. Peptides were greater than 98% pure on the basis of high 
pressure liquid chromatography analysis. Binding of MBP peptides to 
purtfted DRB1’1501 molecules was determined as previously de- 
scribed (Wucherpfennig et al., 1994). In brief, purified DRBl’l501 
molecules (l-5 uM) were incubated for 48 hr with 100 nM ‘PI-radio- 
labeled peptides and various doses of unlabeled MBP analog peptides 
in the presence of a protease inhibitor cocktatl. Relative capacity of 
MBP peptides to inhibit the binding of MHC molecules and radiola- 
b&d ligands, expressed asaconcentration of MBP peptide(micromo- 
lar) yielding half-maximat inhibition, is the measure of the affinity of 
MBP peptides for MHC isotypes. 
T till Prollkratlon Assays 
For all T cell stimulation assays, the homoxygous B cell line 9010 
(DR2/DD6) was used as APCs. APCs were pulsed wtth psptide at 
I-100 @ml for 2 hr, washed and irradiated with 5000 rads. T cells 
(5 x IO’) and APCs (2 x IO’) were then cocultured in triplicate for 3 
days in 200 pl complete medium at 37OC. During the last 18 hr of 
culture, 1 nCi of PHphymidine was added to each well and T cell 
proliferation measured as PHjthymidine incorporation. Three pluses 
represent proliferation (stimulation index > 3) at 1 ug/ml. two pluses 
represent proliferation at 10 pglml and one plus represents prolifera- 
tion only at 100 rg/ml of peptide. 
TCR Antagonlst Amy 
Live APCs (B cell line 9010 expressing, DRBI ‘1501) were prepulsed 
for 2 hr with a suboptimal dose of MBPp65-99 peptide (2 u@ml) deter- 
mined to provide a less than maximal T cell stimulation. Pulsed APCs 
were irradiated and washed, followed by a second pulse of antigen 
with the altered peptide ligands at 0.1, 1, 10, and 100 pg!ml for 2 hr. 
After another wash, the APCs were plated in 9&well microtiter plates 
and cultured with the T cell clone OblA12 (5 x IO4 APCs and 2 x 
l(rTcellsperwell in tripkcates)andcocultursdfor3days. Proliferation 
was measured as PH]thymidine incorporation after an 18 hr pulse. 
We used the native MBPp65-99 and MBPp85-99(93A), which were 
agonist peptides, as a positive control. 
Phoophoryletlon of ~58’ 
lmmunoprecipitation of CD4 and in vitro kinase assay were performed 
as previously described (Hollsberg et al., 1994; Rudd et al., IWS). In 
brief, OblA12 was stimulated with peptidepulsed APCs for 1 hr. 
washed in phosphatebuffered saline, and tysed in a buffer (pH 8.3) 
containing 1% Triton X-100, 20 mM Tris, 150 mM NaCI, and 1 mM 
phenylmethylsulfonyt fluoride. Lysateswere p&eared with Staphylo- 
coccus aureus cells and incubated with OKT4-coated protein A Sepha- 
rose beads for 1 hr. The immunoprecipitate was washed twice in lysis 
buffer and incubated in a [ySPPpITP kinase buffer for IO min. The 
reaction was stopped by the addition of 2x sample buffer. Samples 
were boiled for 5 min and separated on a 10% SDS gel. Autoradiogra- 
phy was done for 30 min on Kodak XAR 5 film. 
ce+ Flux 
T cells (1 07/ml) were loaded with indo-l acetoxymethyl ester (Molecular 
Probes, Junction City, Oregon) at 2 pg/ml in cuiture medium for 45 
min at 37OC and then diluted I:10 in culture medium. APCs were 
pulsed with peptide at 100 pg’ml for 2 hr, washed in RPMI, and resus- 
pended in culture medium. T cells (lm snd APCs (5 x lm were run 
on an Epics V flow cytometer to establish a baseline. Then, cells were 
spun for 1 min at 1200 rpm to establish cell-to-cell contact and rerun 
on the flow cytometer for up to 600 s. After Ca% binding, the In-1 
dye exhibits changes in fluorescence emission wavelength from 480 
to 410 nM. The ratio of 41WSft nm in&l fluorescence was recorded 
versus time and expressed in arbitrary unlts, one arbttrary unit repre- 
senting approximately 200 nM increase of Ca-. Addition of ionomycin 
(4~g/ml)wasusedasapositiiwntrolandEGTA(5~g/ml)asnegatlve 
control. 
Meeeurement of Cytofdne mRNA 
B cells (9010) were pulsed with the psptides as described above. 
T cells(106)were thencocuftursdwlth 4 x l(rAPCs ln2OOnl medium 
in U-bottomed wells for 4 hr, followed by RNA extraction and cDNA 
synthesis. Total cellular RNA was extracted using the RNAzol B 
method (Teltest, Incorporated, Friendswood, Texas). RNA was copre- 
cipttated with 10 ng of transfer RNA in isopropanol overnight. For cDNA 
synthesis, the pellet was resuspended in 6 ul of sterile double-distilled 
water, 5 pl of oligodT (Sigma) and random hexamers (Pmmega) were 
added, and the samples heated to 70°C for 10 min. Then, 4 pl of 5x 
buffer, 2 ul of 0.1 M DTT, and 1 pl each of 10 mM dNTPs, RNA&, and 
M-MLV reverse transcriptase (all from Promega) were added. cDNA 
synthesis was carried out at 37OC for 80 min and water added to a 
final volume of 200 cl. Sampfes were normalized to the Bgctin cDNA 
wncentration as determined by wmpsttttve RT-PCR using a nonho- 
mologous DNA fragment of known concentration that has the same 
primer annealing sites and amplifies with the same efficiency as the 
internal standard (data not shown). The PCR for TGF-5 and IL-4 was 
semiquantitative, with 25 amplification cycles of denaturation at 94OC 
for 1 mitt, of annealing at 60°C for 1 min, and of extension at 72OC 
for 90 s, which was determined to be within the linear range of 
the PCRs. Concentrations in the PCRs were as previously reported 
(Wucherpfennig et al., 1990), except for the addition of 0.6 pCi of 
PP-labefed dCTP to each reaction. Forward primer for TGF+l was 
5%CC CTG GAC ACC MC TAT TGC-3’; reverse primer was 5’GCT 
GCA ClT GCA GGA GCG CAC-3’; PCR product length is 336 bp. 
Primers for IL-4 were as follows: forward primer was 5’CTG CTA GCA 
TGT GCC GGC AAC llT GTC CAC-3’; reverse primer was 5’GAA 
GlTlTCCAACGTACTCTGGlTGGCTTC-3’; IengthofPCRproduct 
is 365 bp. 
Radioactive PCR products were separated on 5% potyacrylamide 
gel and visualized by autoradiography. 
Cytoldne EUBA 
Tcells(l@)from OblAl2wsrestimulated in5ml polypropylenstubes 
with 4 x 10 peptiwulsed APCs (9010 B cells) pulsed wfth peptkfe 
for 2 hr. Culturesupernatantsfor 11-2. IL4, IL-IO, and IFNyweretaken 
after 40 hr. To measure secretion of actlve TGF-51, the cells were 
then washed carefully three times in RPM1 to remove all serum and 
resuspended in serum-free medium X-Vivo 20 supplemented with 2 
U rlL2/ml and 2 U rlL4/ml (Soehringer Mannheim). Supernatant for 
TGF-fJl ELISA was harvested after 72 hr from start of exPsrlment. The 
ELISA was done for active TGF-ftl and was performed as described 
previously (Miller et al., 1993). For the detection of IL4 and IL-IO. 
primary and secondary antibodii were purchased from Pharmingen 
and used following the suggestions of the manufacturer. IL-2 was as- 
sayed using the ELISA kit from Endogen. For IFNy, the primary anti- 
body was obtained from Genzyme; the secondary from Bkeource In- 
ternational. Assays were done in duplicate. To study the effect of 
ionomycin and PMA on IL4 secretion T cells (2 x 106) and APCs (106) 
were cccuitursd in triplicate welts for 40 hr in 200 ul complete medium 
supplemented wtth kmomycin at 100 nglml or PMA at 10 rig/ml. 
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